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A 5-year-old Dexter cow in the ﬁfth month of preg-nancy was referred to the Clinic for Ruminants
and Swine, Department of Veterinary Medicine, Freie
Universit€at Berlin, Germany, by a local practitioner due
to general weakness and ataxia that did not respond to
treatment. Approximately 3 months before hospitaliza-
tion the cow had suﬀered from two bouts of acute cat-
arrhal mastitis, which were successfully treated by
frequent milking and parenteral administration of tylo-
sina at a dosage of 10 mg/kg bodyweight once daily on
ten consecutive days. Approximately 6 weeks after the
second bout of mastitis (2 weeks before hospitalization),
the cow had weakness and ataxia. There was severe
hypoglycemiab (glucose concentration 21.6 mg/dL)
while complete blood cell counts and diﬀerentials,
bilirubin, blood urea, creatinine, magnesium, calcium,
phosphate and iron concentrations remained within the
reference range.c
At examination, the cow’s posture was characterized
by a wide-based stance and reluctance to walk. The cow
had symmetrical ataxia and hypermetria of all limbs,
intention tremors of the head and a deﬁcit in its menace
responses. The ataxia was graded as 34 out of 5.1 The
cow demonstrated bilateral mydriasis and delayed
pupillary reﬂexes (both direct and indirect). Other cra-
nial nerve function and spinal reﬂexes were normal and
there were no indications of head tilt, tail weakness,
bladder atony, and perineal hypalgesia. The cow
showed no signs of circling. Given the symmetrical
ataxia and hypermetria of all limbs, the intention tre-
mors and the deﬁcit in its menace responses the tenta-
tive neurologic diagnosis was cerebellar ataxia. The
body condition score was assessed 2 of 5.2 Respiratory
rate (36/min), heart rate (72/min), and body tempera-
ture (38.7°C) were within the reference range. Upon
examination of the digestive tract, dysphagia was
observed while the animal was ruminating. Rumen ﬂuid
was dripping from the oral cavity and a discharge con-
taining rumen ﬂuid was draining from the nostrils inter-
mittently. Urinalysis yielded normal results. The color
of urine was yellow to light amber and the speciﬁc grav-
ity was normal (1.030; reference range 1.025–1.045).
Neither glucose nor ketone bodies were detected in the
urine.
CBC and serum biochemistry revealed a low reticulo-
cyte count (5.63 9 106 lL; reference range 6–
8 9 106 lL) and a slight left shift (band neutrophils
0.31 9 103 lL; reference range 0–0.3 9 103 lL, seg-
mented neutrophils 1.26 9 103 lL; reference range 1.3–
4.5 9 103 lL), increased AST (86 U/L; reference range
0–50 U/L) and CK activities (860 U/L; reference range
0–150 U/L). Venous blood gas analysis identiﬁed a
slightly increased Base Excess (6 mmol/L; reference
range 3–+3 mmol/L), while the blood pH was within
the reference range (7.39; reference range 7.35–7.45).
NEFAd (0.6 mmol/L, reference range ≤0.4 mmol/L)
were slightly increased, but beta-hydroxybuyratee
(0.2 mmol/L, reference range ≤1.0 mmol/L) was nor-
mal. The plasma glucose concentration revealed insuli-
noma as a tentative diagnosis based on the normal
BHB concentration a negative energy balance was con-
sidered unlikely. The increase in the activity of AST
and CK was probably because of transportation. To
exclude cerebrocortical necrosis, serum total
thiamine concentration was determined by HPLC tech-
nique.3 Total thiamine was 41 lg/L (reference range of
>50 lg/L).
No abnormalities were detected on endoscopy of the
upper gastrointestinal and respiratory tracts or ultra-
sonographic examination of the liver, gallbladder,
spleen, intestine, rumen, reticulum and kidney. On
transabdominal ultrasonographic examination, preg-
nancy in an advanced stage was ascertained and fetal
viability conﬁrmed by measuring fetal heart rate (110
beats/min; normal fetal heart rate 90–125 beats/min).
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Persistent hypoglycemia was demonstrated on four
consecutive days starting from the day after admission.
The Dexter cow was initially treated with glucogenic
precursors (40 g propylene glycol and 40 g glycerol
twice daily), which were administered orally to control
hypoglycemia. The treatment of hypoglycemia with cor-
ticosteroids was not performed to avoid the risks of
abortion. Serum samples for determination of insulin,
estrogen, and cortisol were sent to the Endocrinology
Laboratory, Clinic for Cattle, Tier€arztliche Hochschule
Hannover. A radioimmunoassay was applied for the
quantitation of serum insulin concentrations in cattle.f
The details for the analysis of above-mentioned vari-
ables have been described by Meyerholz (2014). Estro-
gen (246 pg/mL; reference range >20 pg/mL for
pregnant cows) and progesterone (6.3 ng/mL; reference
range >5 ng/mL for pregnant cows) were detectable and
conﬁrmed pregnancy. Cortisol was also detectable
(19.8 ng/mL; reference range >2 ng/mL) ruling out
adrenal insuﬃciency as a cause of persistent hypo-
glycemia. Plasma glucose concentrations were extremely
low (33.3, 25.2, 30.6, 27.0 mg/dL; reference range 40–
59 mg/dL) and serum insulin concentrations exceeded
300 pmol/L in three of the four samples (316, 333, 109,
and 501 pmol/L, respectively; reference range Holstein
Friesian heifers 54–194 pmol/L) on 4 days during hos-
pitalization. The latter levels were higher compared to
those reported in literature when the same assay had
been applied in pregnant primiparous cows4 and also
when a similar method had been applied in pregnant
multiparous cows.5 No reference values, however, are
available for serum insulin concentration in Dexter
cows.
Due to persistent hypoglycemia and hyperinsulinemia
in the absence of ketonemia, an insulin-secreting tumor
was suspected. An intravenous glucose tolerance test
(IVGTT) was performed to support this diﬀerential
diagnosis. A long-term catheterg was placed in the left
jugular vein under aseptic conditions and connected
with a three-way stopcock ﬁtted with an extensionh
tube. The tube was ﬁxed to the skin with two simple
interrupted sutures. The system was ﬁlled with hep-
arinised normal saline solution (50 IU/mL) and blood
samples for determination of glucose and insulin con-
centrations were drawn from the catheter into appropri-
ate 9 mL tubesi after disposal of the 5 mL of aspirated
ﬂuid. Following collection of the initial blood sample, a
volume of 500 mL of 5% glucose solutionj was adminis-
tered over a period of 5 minutes through the long-term
catheter (170 mg glucose/kg BW) and serial blood sam-
ples were obtained at 30 minutes and 1-hour intervals
following glucose administration. From an initial level
of 27.7 mg/dL glucose levels crossed the lower limit of
the reference range (40 mg/dL) at 30 minutes following
the start of the infusion, and decreased to below base-
line at 90 minutes (Fig 1). Insulin concentrations
crossed a high peak concentration (2180 pmol/L) from
an initial level of 54 pmol/L and decreased to a level of
322 pmol/L at 30 minutes postinfusion and remained
elevated over the baseline concentration 5 hours long
postinfusion (Fig 1). Determination of the glucose/
insulin ratio, which is the standard approach for diag-
nosis of insulinoma in dogs6 and humans,7 was not con-
sidered an appropriate diagnostic tool in cattle as the
physiological range of insulin secretion and concentra-
tion in Dexter cows is unknown. The results of IVGTT
reﬂecting persisting hyperinsulinemia after plasma glu-
cose levels had already returned to subnormal levels
further supported suspicion of an insulin-secreting
tumor. From the results of the IVGTT, it was con-
cluded that persisting hyperinsulinemia associated with
hypoglycemia as observed at IVGTT in this Dexter cow
was demonstrative of an insulinoma. Hypoglycemia in
cattle is a common ﬁnding related to malnutrition in
young stock8 or to negative energy balance in the tran-
sition period.9 In contrast to the case presented here,
hypoglycemia originating from deﬁcient energy supply
or increased demands of energy due to lactation is asso-
ciated with increased levels of NEFA and BHB due to
lipomobilization and ketone body production. The Dex-
ter cow did not respond with ketone body production
or excessive lipomobilization in the face of hypo-
glycemia. This ﬁnding indicated a blockade of lipolysis
and ketone body formation, most likely due to persis-
tent hyperinsulinemia which inhibits lipolysis and subse-
quent ketone body production.10 The mildly increased
NEFA levels of the Dexter cow might be due to cate-
cholamine-induced lipolysis, which cannot be inhibited
by insulin due to reduced antilipolytic eﬀect of insulin
in pregnancy.10 The absence of excessive lipomobiliza-
tion and ketosis as well as persistence of hyperinsuline-
mia observed following glucose administration,
however, do justify the assumption of insulinoma but
are not conclusive as the insulin response to intravenous
glucose infusion is physiologically high (Peak values
range between 137–1728 pmol/L) in dairy cows, as
demonstrated in two previous studies.11,12 In humans,
the term insulinoma is used to describe small tumors
composed of islet cell tissue that develop in the pan-
creas and ectopic sites and cause hypoglycemia by their
ability to secrete insulin.13 The clinical diagnosis of
insulinoma in humans is based on the presence of
Whipple’s triad, consisting of the presence of clinical
signs such as tremor, sweating, tachycardia, loss of con-
sciousness, giddiness, and blurring of vision that occur
intermittently,14 persistent hypoglycemia during fasting
and, improvement of clinical signs after infusion of glu-
cose.15 Signs of neurologic dysfunction were reported in
30 patients with insulinoma.16 Confusion, coma, convul-
sions, and weakness were predominant ﬁndings in these
patients.16 Magnetic resonance imaging and computed
tomography are alternative diagnostic tools applied in
humans and small animals. Recently, intraabdominal
ultrasonography was added to the diagnostic spectrum
in humans to increase the diagnostic sensitivity of
insulinomas.15 Biochemical diagnosis of insulinoma in
humans relies on unequivocally measurable insulin con-
centrations in the fasting state, the concurrent measure-
ment of C-peptide together with quantitation of ketone
bodies.7 Furthermore, evaluation of the insulin–glucose
ratio is an important diagnostic parameter with a sensi-
tivity of 93% and speciﬁcity of 94%.7 In the present
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case, the two monoclonal spikes in the alpha 1-fraction,
which were detected by serum electrophoresis,
were probably due to pregnancy or increased levels of
C-peptide. However, a validated C-peptide assay for use
in cattle is not available yet.
All treatment attempts including providing glucogenic
nutrients and precursors (oral administration of 40 g
propylene glycol and 40 g glycerol twice daily through-
out hospitalization) failed and the condition of the cow
deteriorated during hospitalization. Furthermore, she
had an abortion approximately in the sixth month of
pregnancy. Abnormalities were not detected on post-
mortem examination of the fetus. Abortion might have
been caused by undersupply of the fetus with glucose
due to hypoglycemia of the mother. In pregnant cows,
glucose crosses the uterus and placenta insulin-indepen-
dently by the primary glucose transporters (GLUT1
and GLUT3). A maternal hypoglycemia aﬀects the fetal
glucose uptake directly because the fetus and placenta
cannot sequester glucose against its concentration gradi-
ent and the capacity of the fetus and placenta is limited
to compensate hypoglycemia by gluconeogenesis.17 Due
to the clinical condition and the unfavorable prognosis,
euthanasia was elected and necropsy was performed at
the Institute of Veterinary Pathology, Faculty of Veteri-
nary Medicine (Freie Universit€at Berlin).
At necropsy, multifocal, partially encapsulated, highly
inﬁltrative, white-grey nodules with a maximal diameter
of 2.8 cm were present in the right lobe of the pancreas
(Fig 2). White nodes in pancreaticoduodenal and
mesenteric lymph nodes were seen in addition. Addi-
tional ﬁndings were chronic enteritis and a moderate
chronic ulcerative abomasitis. The proposed cause of
abomasitis was chronic stress during hospitalization.
For histological evaluation, pancreatic tissue and lymph
nodes were ﬁxed by immersion in 10% neutral-buﬀered
formalin for 96 hour and paraﬃn-embedded. Sections
of 4 lm in thickness were routinely stained with hema-
toxylin and eosin (HE). These showed a multiple inﬁl-
trative coalescing neoplastic masses of polygonal tumor
cells arranged in nests and packets, overall showing a
neuroendocrine pattern (Fig 3). Multifocal necrosis and
hemorrhage were present. Tumor cells had high
amounts of intensely eosinophilic cytoplasm (Fig 3) and
mitotic rate was low. Moderate pancreatic atrophy was
present in the adjacent exocrine pancreas. The afore-
mentioned lymph nodes were almost completely inﬁl-
trated by the tumor cells, resulting in a replacement of
original lymphoid tissue. Intravascular tumor cells were
frequently observed. For a deﬁnitive diagnosis of the
neoplasm, immunohistochemistry using anti-human
insulin antibodies,k anti-chromogranin A, anti-synapto-
physin and anti-melan A was performed following rou-
tine protocols with a 15 minutes microwave heating
step in citrate buﬀer pH 6.0 as retrieval method for
anti-chromogranin A, anti-synaptophysin and anti-
melan A. A biotinylated goat anti-mouse antibody
diluted 1 : 200 was used as secondary antibody for all
antibodies except anti-insulin (goat anti-guinea pig).
Color development was performed using DAB and
hemalaun as counterstain. The expected staining pattern
for islet cell tumors is similar in diﬀerent domestic ani-
mals. Cells stain positive for chromogranin A or B
depending on the neoplastic cell type, protein gene pro-
duct 9.5 (PGP9.5, synonym Ubiquitin carboxy-terminal
hydrolase L1), synaptophysin or neuron speciﬁc enolase
(NSE). In insulinomas, tumor cells are additionally pos-
itive for insulin.18 Immunohistochemistry conﬁrmed the
clinical diagnosis of insulin-producing islet cell tumor in
both the pancreatic neoplasm and the lymph nodes,
with the anti-insulin antibody yielding strong intracyto-
plasmic signals with occasional membrane staining
(Fig 4). In addition, the neoplastic cells were melan
A-negative, chromogranin A-negative, and synapto-
physin-positive (not shown). Although tumor cells
stained unexpectedly negative for chromogranin A, the
positive staining for both synaptophysin and especially
insulin support the diagnosis of an insulinoma. Incuba-
tion of the slides with an irrelevant antibody as negative
control did not result in speciﬁc staining (not shown).
Insulinomas are endocrinologically active tumors of
the pancreas derived from pancreatic beta cells and
have been reported in humans14 and a number of ani-
mal species.6,19,20 Insulinoma in cattle has previously
been identiﬁed by immunohistochemistry and light
microscopy of suspected neoplasms encountered in the
slaughterhouse at routine meat inspection.20 Most of
pancreatic tumors have been described as islet cell
tumors and most of them were classiﬁed as malignant.20
In humans, insulinomas are described as usually
Fig 1. Plasma glucose and serum insulin concentrations during
intravenous glucose tolerance test using 170 mg glucose/kg BW in
the Dexter cow. Fig 2. Pancreas with multifocal whitish nodules, formalin-ﬁxed.
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solitary, benign, and encapsulated small lesions with a
diameter <2 cm.13 Other pancreatic tumors that can
cause hyperinsulinemia include pancreatic polypeptide-
secreting tumors (PPomas), as described in dogs.6 Clini-
cal signs, however, are typically absent or go unnoticed
in case of tumors that primarily produce pancreatic
polypeptide in dogs.21 Pancreatic tumors, that produce
both pancreatic polypeptide and insulin, can cause per-
sistent hypoglycemia due to hyperinsulinemia.19,21
Therefore, histopathological examination of pancreas
tissue is necessary in order to achieve an exact diagnosis
of insulinoma.19 A paraneoplastic hypoglycemia is an
important diﬀerential diagnosis of insulinoma and
occurs due to a nonislet cell tumor that secrets incom-
pletely processed IGF-II, which causes glucose con-
sumption by interacting with IGF and insulin receptors
directly.6,22 The determination of IGF-I and IGF-II
levels in serum and IGF-II:IGF-I ratio can help to con-
ﬁrm or rule out the diagnosis of paraneoplastic hypo-
glycemia.6,22 Further diﬀerential diagnoses of
insulinoma, which might cause a persistent hypo-
glycemia, include disorders of counter regulatory hor-
mone release (glucagon, epinephrine, growth hormone,
and cortisol), especially adrenal insuﬃciency.23 Adrenal
insuﬃciency is either congenital or acquired and charac-
terized by an insuﬃcient production of steroid hor-
mones (glucocorticoids and often mineralocorticoids).
ACTH stimulation test can establish the diagnosis and
distinguish whether it is primary or secondary adrenal
insuﬃciency.23 Addison’s disease (chronic adrenal insuf-
ﬁciency) can occur as a result of a primary disorder of
the adrenal gland or secondary to a deﬁciency of
hypothalamic and pituitary hormones such as adreno-
corticotropic hormone (ACTH) or corticotropin-releasing
hormone (CRH).23 Adrenal insuﬃciency has never been
described in cattle except one case24 and was ruled out
in the present case by evaluation of cortisol and potas-
sium concentrations. Neither disorders of counter
regulatory hormone release nor nonislet cell tumors are
associated with hyperinsulinemia, contrary to insuli-
noma. Animals with insulinoma do not exhibit a com-
pensatory drop of insulin secretion in the presence of
hypoglycemia.25 Therefore, IVGTT seems to be the
diagnostic method of choise for insulinoma in cattle, to
characterize the regulation of insulin release and the
pancreatic insulin response to changes in glucose levels.
Surgical excision of neoplastic tissue is treatment of
choice in humans14 and ferrets.19 In dogs, the long-term
medical treatment is applied by oral administration of
diaxozide possibly in combination with prednisolone.6
A partial pancreatectomy contributed to a longer sur-
vival time in dogs with insulinoma.6 Persistent hypo-
glycemia in the absence of ketosis in adult dairy cattle
presenting with signs of neurologic dysfunction could
indicate the presence of an insulinoma. The present case
of a cow with signs of neurologic dysfunction associated
with persistent hypoglycemia and hyperinsulinemia
illustrates a case of an insulinoma with inhibition of
lipolysis and ketogenesis. When diagnosis is reached
in vivo, glucocorticoid medication in combination with
partial pancreatectomy might be attempted, but possible
metastases have to be considered.
Fig 3. Polygonal neoplastic cells with high amounts of eosinophi-
lic cytoplasm arranged in a neuroendocrine pattern of nests and




Fig 4. (A) Anti-insulin immunohistochemistry showing variably
intense cytoplasmic staining of neoplastic cells. (B) Higher magniﬁ-
cation. Note that not all neoplastic cells are positive for insulin.
DAB staining (brown) with hematoxylin counterstaining (blue).
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Footnotes
a Tylosel-200, Selectavet, am K€ogelberg 5, 83629 Weyarn-Holzol-
ling
b Vet ABC, Fa. Scil, Viernheim
c Cobas Mira Plus (Fa, Roche, Mannheim)
d FA 115 kit, Randox Labarotories Ltd., Crumlin, UK
e Ranbut kit RB1007, Randox Labarotories Ltd., Crumlin, UK
f IM3210, insulin IRMA KIT, Immunotech, Beckman Coulter,
CA
g VasoVet G14, B. Braun, Melsungen AG, Melsungen, Germany
h Discoﬁx-3, B. Braun, Melsungen AG, Melsungen, Germany
i Tube 9 mL Sarstedt Monovette AG & Co. Sarstedt N€urnbrecht,
Deutschland
j Glucose 5%, B. Braun Melsungen, Germany
k Dako, Hamburg, Germany
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